We use cookies on our site to track usage and preferences. Learn more

Latest news

Showing 24/1498 results

  • Take-up continues at 101 Cambridge

    None

    Mon 25 Oct 2010

  • Cambridge businesses join forces to help homeless youngsters

    None

    Wed 6 Oct 2010

  • Technology

    Wireless Experts Say The Signal Is Clear For Whitespace

    None

    Wed 6 Oct 2010

  • Festival of Ideas 2010

    None

    Wed 29 Sep 2010

  • TP+ Bicycle User Group Meeting

    None

    Wed 29 Sep 2010

  • Technology

    picoChip and Cambridge Consultants collaborate on LTE Femtocell platform enhancement

    None

    Thu 23 Sep 2010

  • Global Poverty and ICTs

    None

    Mon 20 Sep 2010

  • The British Science Association in Cambridge

    The British Science Association are looking for enthusiastic volunteers to join their new Cambridgeshire branch.

    Mon 6 Sep 2010

  • Technology

    Breathe™ easy: Cambridge Consultants technology adds intelligence and automation to aspiration procedures

    None

    Fri 27 Aug 2010

  • Putting the patient first: students work with elderly to define the next stage of the connected health revolution

    None

    Fri 20 Aug 2010

  • Astex and Multiple Myeloma Research Consortium (MMRC) Announce Start of Phase II Clinical Study of AT7519 in Multiple Myeloma

    Cambridge, UK, and Norwalk, Connecticut, USA, 12 August 2010. Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium (MMRC) announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase (CDK) inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (Velcade®).

    Mon 16 Aug 2010

  • FREE - Commuter Stand Service

    None

    Fri 30 Jul 2010

  • ASIAN PROGRESS FOR OWLSTONE

    A new order from a Japanese technology company for FAIMS development platforms has been received by Owlstone’s Cambridge UK laboratories.

    Mon 26 Jul 2010

  • Life Sciences

    CAMBRIDGE COMPANY WINS ‘OSCAR OF INNOVATION’

    Owlstone Nanotech, Inc., in partnership with Pacific Northwest National Laboratory, has been selected as one of the 2010 R&D100 Award winners.

    Mon 26 Jul 2010

  • Warning: ITC Group

    None

    Thu 15 Jul 2010

  • Congrats to Cambridge Cycle Challenge Winners

    None

    Thu 15 Jul 2010

  • Cambridge Consultants making a splash in the innovative marine industry

    None

    Wed 14 Jul 2010

  • London to Cambridge Cycle Event

    None

    Mon 12 Jul 2010

  • Cambridge Consultants wins competition for Ultra Efficient Lighting

    None

    Mon 28 Jun 2010

  • TP+ Electric Pool Bike

    None

    Thu 24 Jun 2010

  • TP+ Bicycle User Group Event

    None

    Fri 21 May 2010

  • FREE Bike Maintenance Taster Courses

    None

    Tue 11 May 2010

  • Unlicensed whitespace frequencies could revolutionize wireless networks, experts say

    New report offers inside perspectives from industry leaders on the impact of whitespace radio, discussing market opportunities and new wireless products and services

    Thu 22 Apr 2010

  • Cambridge Cycle Challenge

    None

    Mon 19 Apr 2010

  • Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

    Read more